Cyclis Pharmaceuticals

About:

Cyclis Pharmaceuticals Inc. discovers and develops novel small molecule drugs for treatment of cancer

Website: http://www.cyclispharma.com/

Top Investors: Ampersand Capital Partners

Description:

Cyclis is researching and developing small-molecule cancer drugs based on a novel technology designed to selectively kill cancer cells and preserve normal cells by restoring and activating cellular checkpoints known to be defective in cancers.

Total Funding Amount:

$5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Norwood, Massachusetts, United States

Founded Date:

2001-01-01

Founders:

Number of Employees:

Last Funding Date:

2002-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai